These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3125285)

  • 1. [Comparative study of BRL28500 (clavulanic acid-ticarcillin) and ticarcillin in the treatment of respiratory tract infections].
    Miki F; Ikuno Y; Inoue E; Murata A; Tanizawa S; Sakamoto K; Tahara A; Saito A; Tomizawa M; Hiraga Y
    Kansenshogaku Zasshi; 1987 Aug; 61(8):944-79. PubMed ID: 3125285
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of BRL28500 (clavulanic acid-ticarcillin) and piperacillin in the treatment of respiratory tract infections].
    Miki F; Ikuno Y; Inoue E; Murata A; Tanizawa S; Sakamoto K; Tahara A; Saito A; Tamizawa M; Hiraga Y
    Kansenshogaku Zasshi; 1987 Aug; 61(8):914-43. PubMed ID: 3125284
    [No Abstract]   [Full Text] [Related]  

  • 3. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors].
    Tamura M; Ito T
    Nihon Rinsho; 1987 Mar; 45(3):583-7. PubMed ID: 3037135
    [No Abstract]   [Full Text] [Related]  

  • 4. Ticarcillin--clavulanic acid (Timentin).
    Med Lett Drugs Ther; 1985 Aug; 27(694):69-70. PubMed ID: 3894901
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of clavulanic acid/ticarcillin on severe infections accompanying hematological diseases].
    Urabe A; Takaku F; Kitagawa S; Miura Y; Dan K; Nomura T; Masuda M; Mizoguchi H; Yano T; Toyama K
    Jpn J Antibiot; 1987 Apr; 40(4):749-58. PubMed ID: 3613092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].
    Fomina IP
    Antibiot Khimioter; 1997; 42(12):29-32. PubMed ID: 9480651
    [No Abstract]   [Full Text] [Related]  

  • 7. Concentrations of ticarcillin and clavulanic acid in human bone after prophylactic administration of 5.2 g of timentin.
    Adam D; Heilmann HD; Weismeier K
    Antimicrob Agents Chemother; 1987 Jun; 31(6):935-9. PubMed ID: 3619427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in chemotherapeutic agents--beta-lactam antibiotics and beta-lactamase inhibitors].
    Uzuka Y; Matsumoto K
    Nihon Rinsho; 1986 Apr; 44(4):824-30. PubMed ID: 3531574
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid.
    Roselle GA; Bode R; Hamilton B; Bibler M; Sullivan R; Douce R; Staneck JL; Bullock WE
    Antimicrob Agents Chemother; 1985 Mar; 27(3):291-6. PubMed ID: 3888101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ticarcillin/clavulanic acid (Timentin) compared to metronidazole/netilmicin in preventing postoperative infection after elective colorectal surgery.
    Blair JE; McLeod RS; Cohen Z; Devlin HR
    Can J Surg; 1987 Mar; 30(2):120-2. PubMed ID: 3548930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timentin--ticarcillin plus clavulanic acid. A laboratory and clinical perspective. Based on an international symposium. Monte Carlo, 3-4 December 1985.
    J Antimicrob Chemother; 1986 May; 17 Suppl C():1-244. PubMed ID: 3722041
    [No Abstract]   [Full Text] [Related]  

  • 12. Intraperitoneal penetration of ticarcillin/clavulanic acid (Timentin).
    Manek N; Wise R; Donovan IA
    J Antimicrob Chemother; 1987 Mar; 19(3):363-6. PubMed ID: 3494723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies of BRL 28500 (clavulanic acid/ticarcillin) in the treatment of intraperitoneal infections and biliary tract infections].
    Sakai K; Ueda T; Uchino J; Hayasaka A; Shiramatsu K; Nagamachi Y; Shoda Y; Okui K; Hayata Y; Watanabe H
    Jpn J Antibiot; 1987 Apr; 40(4):759-811. PubMed ID: 3302345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection in women. Clinical experience with beta-lactamase inhibitors.
    Holloway WJ
    J Reprod Med; 1988 Jun; 33(6 Suppl):595-7. PubMed ID: 3294405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.
    Parker RH; Eggleston M
    Infect Control; 1987 Jan; 8(1):36-40. PubMed ID: 3028975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticarcillin plus clavulanic acid (Timentin)--further UK trial results.
    Tehan S; Horobin J; Gordonsmith R; McLatchie GR
    Br J Clin Pract; 1988 Jan; 42(1):8-16. PubMed ID: 3058192
    [No Abstract]   [Full Text] [Related]  

  • 17. The antibacterial activity of ticarcillin/clavulanic acid (BRL28500) against ticarcillin-resistant bacteria.
    Kasai T; Nishino T; Kazuno Y; Tanino T
    J Antibiot (Tokyo); 1986 Oct; 39(10):1450-60. PubMed ID: 3536827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial effects of ticarcillin/clavulanic acid in animal models of infection.
    Boon RJ; Beale AS; Sutherland R
    J Antimicrob Chemother; 1986 May; 17 Suppl C():41-6. PubMed ID: 3087934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
    Hou F; Li J; Gao L; Chen Y
    Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytosis and hyperkalemia associated with the use of ticarcillin/clavulanic acid.
    Moody SB; Pawlicki KS
    Drug Intell Clin Pharm; 1987 Mar; 21(3):292-3. PubMed ID: 3569032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.